Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in Lynch Syndrome
Lynch syndrome increases your risk of certain cancers, like bowel or womb cancer. Currently, checking for these cancers often involves colonoscopies or other invasive procedures. While these work, they can be uncomfortable and might stop some people from getting regular checks. This study is exploring a new approach using 'liquid biopsies' – simple tests on samples like blood, urine, or stool. The main goal is to see if these easier tests can help doctors personalise your cancer checks, potentially allowing more time between those less comfortable procedures, while still making sure you get safe and effective monitoring. It's about finding ways to make cancer surveillance better and easier to manage.
Auf einen Blick
Worum geht es in dieser Studie?
Lynch syndrome is a condition passed down through families that makes you more likely to get certain cancers, especially bowel cancer and cancer of the womb. It affects quite a lot of people in the UK.
Right now, doctors mainly keep an eye on things by using procedures like colonoscopies, where a tiny camera looks inside your bowel. They might also take small tissue samples (biopsies) for testing. While these methods are good at finding cancer, they can be a bit uncomfortable and sometimes put people off having their regular checks. This means some might miss out on important monitoring they need.
This study, called PREDI-LYNCH, is looking into a different, potentially gentler way to check for cancer. It uses what are called 'liquid biopsies' – simple tests done on samples like blood, urine, or even stool. For women, it can also involve a vaginal swab. The hope is that these easier tests could help doctors create a more personal checking plan for you, possibly meaning you won't need as many of the more invasive procedures, while still keeping you safe and detecting any cancers early.
Wichtige Erkenntnisse
- Exploring gentler ways to check for cancer in Lynch syndrome.
- Compares standard care with new 'liquid biopsy' tests.
- Aims to reduce invasive procedures like colonoscopies.
- Focuses on samples like blood, urine, and stool.
- Could lead to more personalised cancer checking plans.
- You must have confirmed Lynch syndrome to take part.
Wer könnte berechtigt sein?
To join this study, you need to be an adult between 35 and 80 years old and have a confirmed diagnosis of Lynch syndrome. This means tests have shown you have a specific change in certain genes (MLH1, MSH2, MSH6, or EPCAM).
There are also some reasons you might not be able to take part. For example, if you’ve already had your entire colon and rectum removed, or if you’ve been treated for cancer in the last two years. You also can’t join if you are pregnant or if doctors think you wouldn't be able to keep up with the study's appointments and requirements.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Are you between 35 and 80 years old?
- Do you have a genetically confirmed diagnosis of Lynch syndrome?
- Have you NOT had your entire colon and rectum removed?
- Have you NOT been treated for cancer in the last 2 years?
- Sind Sie in der Lage und bereit, an allen Studienterminen teilzunehmen?
- Are you NOT currently pregnant?
Was beinhaltet die Teilnahme?
If you join this study, you will either continue with the standard follow-up, which includes a colonoscopy every 18 months, or you will have a yearly 'liquid biopsy' (providing blood, urine, stool, and potentially vaginal samples) along with a colonoscopy every 36 months. If any of your liquid biopsy tests show something unusual, you will have extra checks straight away to confirm the results.
The study will also look at your quality of life and how healthcare is used. You'll have regular appointments to provide samples and sometimes undergo a colonoscopy. The exact duration of your participation will depend on which group you are in and will be explained fully by the study team.
Potenzielle Risiken und Vorteile
Standorte (9)
- Klinicki Bolnicki Centar Sestre Milosrdnice UstanovaVerifizierte PostleitzahlZagreb, Kroatien
- Masaryk Memorial Cancer InstituteVerifizierte PostleitzahlBrünn, Tschechien
- Tampereen Korkeakoulusäätiö SRVerifizierte PostleitzahlHelsinki, Finnland
- GGC NetworkVerifizierte PostleitzahlParis, Frankreich
- Ist. Tumori di MilanoVerifizierte PostleitzahlMailand, Italien
- Pauls Stradins Clinical University HospitalVerifizierte PostleitzahlRiga, Latvia
- Erasmus Medisch Centrum RotterdamVerifizierte PostleitzahlRotterdam, Niederlande
- Oslo University HospitalVerifizierte PostleitzahlOslo, Norway
- Universität EdinburghVerifizierte PostleitzahlEdinburgh, Vereinigtes Königreich
Häufige Fragen
Was ist das Lynch-Syndrom?
Lynch syndrome is an inherited condition that increases your risk of developing certain cancers, like bowel and womb cancer.
What are 'liquid biopsies'?
Liquid biopsies are simple tests performed on samples you can provide easily, like blood, urine, or stool, to look for signs of cancer.
Will I still need colonoscopies if I join?
Yes, colonoscopies are still a part of both study groups, but for some, the aim is to potentially reduce how often you need them.
Ist diese Studie sicher?
The study aims to maintain effective cancer monitoring while exploring safer and less invasive methods. Any unusual test result will be followed up quickly.
Was passiert, wenn ich meine Meinung über die Teilnahme ändere?
Sie können jederzeit aus der Studie austreten, ohne dass dies Ihre medizinische Versorgung beeinträchtigt.
Wie Sie mehr erfahren können
Amina Ghorbel, PhD
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.